![Ganesh Venkataraman Kaundinya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ganesh Venkataraman Kaundinya
Directeur Général chez
GlycoEra AG
Profil
Ganesh Venkataraman Kaundinya was the founder of Momenta Pharmaceuticals, Inc., founded in 2001, where the title held was Chief Operating Officer & Chief Scientific Officer from 2017 to 2018.
The current job is President, Chief Executive Officer & Director at GlycoEra AG, starting in 2020.
Former jobs include Bioinformatics Director at Consortium for Functional Glycomics from 2000 to 2003 and Member-Research Faculty at Harvard University from 1995 to 2000.
Education includes graduate and doctorate degrees from the Massachusetts Institute of Technology.
Postes actifs de Ganesh Venkataraman Kaundinya
| Sociétés | Poste | Début |
|---|---|---|
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology Develops novel biologics to transform the treatment of autoimmune diseases | Directeur Général | - |
Anciens postes connus de Ganesh Venkataraman Kaundinya
| Sociétés | Poste | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Fondateur | 05/10/2018 |
Consortium for Functional Glycomics
 Consortium for Functional Glycomics Internet Software/ServicesTechnology Services Operates software platform for providing data about community activities | Corporate Officer/Principal | 01/01/2003 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/07/2000 |
Formation de Ganesh Venkataraman Kaundinya
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Consortium for Functional Glycomics
Consortium for Functional Glycomics Internet Software/ServicesTechnology Services Operates software platform for providing data about community activities | Technology Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology Develops novel biologics to transform the treatment of autoimmune diseases | Health Technology |
